HCA — HCA Healthcare, Inc.

Is HCA overbought or oversold? Here is the current MarketMoodz read.

Healthcare · Medical Care Facilities

Neutral As of August 19, 2026

HCA Healthcare, Inc. (HCA) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Healthcare name (Medical Care Facilities) last closed at $407.05. The rating moved from Overbought to Neutral on August 13, 2026.

AI analysis

HCA Healthcare, Inc. (HCA) is a large, cash-generative hospital operator with scale advantages, diversified revenue streams across acute and ambulatory settings, and demographic-driven procedure demand. Operational improvements and a strategic shift toward outpatient and higher-margin service lines support margin durability and free-cash-flow growth. Near-term market conditions are calm, leaving the stock subject primarily to company fundamentals and earnings commentary. Key upside catalysts include continued elective-procedure recovery, margin expansion from efficiency initiatives, and sustained patient volumes. Principal risks include payer reimbursement pressure, labor-cost inflation, regulatory changes, and volume sensitivity to macro or public-health shocks. Overall the business profile is resilient, but execution on cost control and payer negotiations will determine near-term performance.

Key factors

  • Large scale and market share across acute care and ambulatory services with strong referral networks
  • Consistent, high free cash flow generation enabling capital returns, M&A optionality, and balance-sheet flexibility
  • Demographic tailwinds (aging population) supporting demand for inpatient and outpatient procedures
  • Operational efficiency programs and shift toward higher-margin outpatient services improving long-term margins
  • Pricing power in many local markets and diversified payer mix helps mitigate single-payer exposure
  • Recent macro quietness and steady order flow reduce near-term market volatility for the stock

Risks

  • Reimbursement pressure from payers and Medicare Advantage plan changes that compress hospital margins
  • Sustained labor cost inflation and staffing shortages increasing operating expenses
  • Volume risk if elective procedures weaken or if macro weakness reduces discretionary care
  • Regulatory and policy risk (pricing transparency, antitrust, healthcare reimbursement reforms)
  • Episode-of-care and value-based payment expansion could cap revenue growth if not managed
  • Geopolitical or public-health shocks (e.g., pandemic resurgence) that shift case mix and capacity

See today's live rating, score and targets

Members see the live hourly rating for HCA — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.